Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision | ||
total_cholesterol [2025/01/28 04:42] – created admin | total_cholesterol [2025/01/28 05:01] (current) – admin | ||
---|---|---|---|
Line 1: | Line 1: | ||
+ | |[[clinical_biochemistry_section|Home]]|[[clinical_biochemistry|]]|[[examination_procedures|]]| | ||
- | | + | Total Cholesterol Examination Procedure |
**1.Purpose of Examination: | **1.Purpose of Examination: | ||
To lay down standard operating procedure for serum Total Cholesterol estimation by CHOD-PAP Method in Biochemistry section of LSSTH, Bhavnagar. | To lay down standard operating procedure for serum Total Cholesterol estimation by CHOD-PAP Method in Biochemistry section of LSSTH, Bhavnagar. | ||
- | **2.Principle of the procedure used for examinations: | ||
- | 1)Cholesterol ester+H2O | ||
- | | ||
- | Cholesterol+F.A | ||
- | | + | **2.Principle of the procedure used for examinations: |
- | | + | The Cholesterol2 assay is an automated clinical chemistry assay. Cholesterol esters are enzymatically hydrolyzed by cholesterol esterase to cholesterol and free fatty acids. Free cholesterol, |
- | | + | (quinoneimine |
- | Which is quantitated at 500 nm. | + | |
**3.Performance: | **3.Performance: | ||
Line 20: | Line 16: | ||
**4.Type of Primary Sample:** | **4.Type of Primary Sample:** | ||
- | Serum or Plasma | + | Serum or Plasma |
**5.Patient Preparation: | **5.Patient Preparation: | ||
Line 34: | Line 30: | ||
**8.Enviromental & Safety control:** | **8.Enviromental & Safety control:** | ||
- | Reagent R1 contains sodium azide.contact with acids liberates very toxic gas | + | Reagent R1 contains sodium azide. contact with acids liberates very toxic gas |
**9.Precautions: | **9.Precautions: | ||
Line 56: | Line 52: | ||
* Press run. | * Press run. | ||
- | **15.Quality Control Procedure: | + | **12.Quality Control Procedure: |
The Laboratory runs Lypocheck Assayed Chemistry Control level 1 & level 2 Once a day. Monthly L-J charts are reviewed & for any QC outlier root cause analysis are done & corrective actions are taken according to the error. | The Laboratory runs Lypocheck Assayed Chemistry Control level 1 & level 2 Once a day. Monthly L-J charts are reviewed & for any QC outlier root cause analysis are done & corrective actions are taken according to the error. | ||
The Laboratory Participates in EQAS programme EQAS report is reviewed and if any result go outlier, then root cause analysis is done & corrective actions are taken according to the error. | The Laboratory Participates in EQAS programme EQAS report is reviewed and if any result go outlier, then root cause analysis is done & corrective actions are taken according to the error. | ||
- | **16.Interferences & Cross-Reactions: | + | **13.Interferences & Cross-Reactions: |
InterferingSubstance | InterferingSubstance | ||
* No interference from Bilirubin up to7.5 mg/dL | * No interference from Bilirubin up to7.5 mg/dL | ||
Line 67: | Line 63: | ||
* No interference from Ascorbate up to 1.5 mg/dl | * No interference from Ascorbate up to 1.5 mg/dl | ||
- | **17.Principle of Procedure for Calculating Results including where relevant, the measurement uncertainty of measured quantity values:** | + | **14.Principle of Procedure for Calculating Results including where relevant, the measurement uncertainty of measured quantity values:** |
Instrument measures the absorbance of a calibrator of known concentration. This point determines the slope of a straight line that relates absorbance to concentration. Instrument calculates a constant which is the inverse of the slope of the straight line. | Instrument measures the absorbance of a calibrator of known concentration. This point determines the slope of a straight line that relates absorbance to concentration. Instrument calculates a constant which is the inverse of the slope of the straight line. | ||
Sample Concentration: | Sample Concentration: | ||
Line 77: | Line 73: | ||
Refer Annexure I | Refer Annexure I | ||
- | **18.Biological Reference Interval:** | + | **15.Biological Reference Interval:** |
Adult : < | Adult : < | ||
- | **19.Reportable interval of patient examination results:** | + | **16.Reportable interval of patient examination results:** |
Up to 500mg/dl | Up to 500mg/dl | ||
Line 87: | Line 83: | ||
* Automated Dilution Protocol | * Automated Dilution Protocol | ||
* When using the Automated Dilution Protocol, the system performs a dilution of the specimen and automatically corrects the concentration by multiplying the result by the appropriate dilution factor. | * When using the Automated Dilution Protocol, the system performs a dilution of the specimen and automatically corrects the concentration by multiplying the result by the appropriate dilution factor. | ||
- | **20.Manual Dilution Procedure: | + | |
+ | **17.Manual Dilution Procedure: | ||
* Dilute the specimen with saline (0.85% to 0.90% NaCl). | * Dilute the specimen with saline (0.85% to 0.90% NaCl). | ||
* Enter the dilution factor in the Patient or Control order screen | * Enter the dilution factor in the Patient or Control order screen | ||
- | **21.Stability of sample** | + | |
+ | **18.Stability of sample** | ||
Serum or plasma-At Room temperature18°–28°C (64°–82°F) stability ≤ 24 hours | Serum or plasma-At Room temperature18°–28°C (64°–82°F) stability ≤ 24 hours | ||
- | **22.Storage of sample** | + | |
- | 2-8° C for 1 days (Retention period for re-examination and/or additional tests is 24 hrs.) | + | **19.Storage of sample** |
- | **23.Reagent Storage and stability** | + | 2-8° C for 1 days (Retention period for re-examination and/or additional tests is 24 hrs.) |
+ | |||
+ | **20.Reagent Storage and stability** | ||
Reagent is stored at 2-8 °c.Reagent stability is 30 days if the reagent is uncapped and on board. | Reagent is stored at 2-8 °c.Reagent stability is 30 days if the reagent is uncapped and on board. | ||
- | **24.Turn around time (TAT)** | ||
- | 6.0 hours after collection, | ||
- | **25.Critical Value:**NA | ||
- | **26.Laboratory Interpretation: | + | **21.Turn around time (TAT)** |
+ | 6.0 hours after collection, | ||
+ | |||
+ | **22.Critical Value: | ||
+ | |||
+ | **23.Laboratory Interpretation: | ||
The common causes of high cholesterol level are as follows : | The common causes of high cholesterol level are as follows : | ||
- | **27.Potential source of variation: | + | **24.Potential source of variation: |
- Expiry of Kit | - Expiry of Kit | ||
- Instrumental Error | - Instrumental Error | ||
Line 111: | Line 113: | ||
- Storage condition not proper | - Storage condition not proper | ||
- | **28.Reagent Handling** | + | **25.Reagent Handling** |
Remove any air bubbles present in the reagents with a new applicator stick, or allow the reagents to sit at the appropriate storage temperature to allow the bubbles to dissipate. To minimize volume depletion, do not use a transfer pipette to remove bubbles | Remove any air bubbles present in the reagents with a new applicator stick, or allow the reagents to sit at the appropriate storage temperature to allow the bubbles to dissipate. To minimize volume depletion, do not use a transfer pipette to remove bubbles | ||
- | **29.REFERENCE: | + | **26.REFERENCE: |
- US department of labor, | - US department of labor, | ||
- US department of health and human services. Biosafety in MIcrobiological and biomedical laboratories. | - US department of health and human services. Biosafety in MIcrobiological and biomedical laboratories. | ||
Line 124: | Line 126: | ||
- NABL 112 effective from 01/06/2019 | - NABL 112 effective from 01/06/2019 | ||
+ | |**Printed copy of this document is considered uncontrolled.** It should be compared with controlled electronic copy before use| | ||
+ | ^ Name of Laboratory : Laboratory Services Sir T. Hospital (LSSTH), | ||
+ | ^Document No.1^**Document Name**: Total Cholesterol Examination Procedure^**Unique ID**:LSSTH /BIOCHEM/ SOP-5^^ | ||
+ | ^Issue No. : 01^Issue Date : | ||
+ | ^Amend No.^ Amend Date ^Prepared by: Section Incharge^Approved & Issued by: HOD, | ||